Outcome of the Board Meeting held on 13.11.2025

Revenue declinedNet loss reportedNegative operating cash flowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.2%Reaction day

₹9.98

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+1.3% vs market

Pharmaceuticals peers, median of 157sector+0.0%+1.2% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.2-0.1+1.3+0.0+1.2

Next day

+7.2+0.5+6.7-0.1+7.4

+7.8-0.3+8.1-0.9+8.7

+3.5-0.5+4.0-1.4+4.9

+3.4-0.8+4.2-1.6+5.0

+2.6-2.3+4.9-2.3+4.9

-1.8-2.8+1.0-3.1+1.3

15d

-0.4-4.9+4.5-3.6+3.2

-3.9-4.7+0.8-4.4+0.5

-9.8-7.7-2.1-5.6-4.2

-16.0-7.8-8.2-10.3-5.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Decipher Labs Limited's board approved unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2025. On a standalone basis, Q2 revenue was just Rs. 8.80 lakhs with a loss after tax of Rs. 11.55 lakhs, and the company has negative other equity of Rs. (167.23) lakhs. On a consolidated basis (including its US and Bahrain subsidiaries), H1 FY26 revenue dropped sharply to Rs. 723.74 lakhs from Rs. 1,330.77 lakhs in H1 FY25, with a net loss of Rs. 340.66 lakhs versus Rs. 38.14 lakhs loss a year ago. Operating cash flow on a consolidated basis was negative at Rs. (218.87) lakhs for H1 FY26. The board also appointed Mr. Dalavath Amar Singh as an Additional Executive Director for two years at Rs. 6 lakh per annum, subject to shareholder approval. The auditor (Ramanatham & Rao) issued a clean, unqualified review report with no qualifications or emphasis of matter.

Likely market impact

Shareholders should note the steep YoY revenue decline (~46%) and wider losses at the consolidated level, along with negative operating cash flows, which signal continued operational stress. The standalone entity's negative net worth and appointment of a new executive director may be efforts to strengthen operations, but near-term financial performance remains weak.